Search
for
Sort by
Research 61–90 of 1000+
- Nanomedicine-based immunotherapy for tissue regeneration
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
- Alopecia and hair repigmentation associated with anti-programmed death-ligand 1 (PD-L1) immunotherapy
- SUN-911 Immunotherapy Use in Adrenocortical Carcinoma with Encouraging Results- a Case Report
- Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series
- Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series
- Allergen‐specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient
- Candida antigen immunotherapy versus steroid in the treatment of alopecia areata
- Home‐based diphenylcyclopropenone immunotherapy for alopecia areata: A large retrospective study of 94 cases
- Comparative trail on efficacy of topical contact immunotherapy with dinitrochlorobenzene and diphenylcyclopropenone in alopecia areata
- Hair Regrowth in a Child with Seasonal Alopecia Areata While Receiving Subcutaneous Aeroallergen Immunotherapy: A Case Report
- Extracellular vesicles as precision therapeutics for psychiatric conditions: targeting interactions among neuronal, glial, and immune networks
- Changes in immune status parameters in patients with alopecia areata undergoing combined therapy
- UTMD Enhances Targeting of Diclofenac and Doxil® to Boost Tumor Immunotherapy
- Immune signatures of psoriasis: Comparison of genetic expression profiles in psoriasis patients after therapy with biologic agents
- Therapeutic small extracellular vesicles from key human stem and immune cellular sources: A review
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Silicate-based therapy for inflammatory dilated cardiomyopathy by inhibiting the vicious cycle of immune inflammation via FOXO signaling
- A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer
- IMMUNE-DRIVEN ACTIVATION OF HAIR FOLLICLE STEM CELLS AS A TRANSLATIONAL MODEL FOR FUTURE CELL-BASED THERAPY DEVELOPMENT
- 861 EGFR/MEK inhibitor therapy induces partial hair follicle immune privilege collapse in vivo and ex vivo
- Extra Virgin Olive Oil as Nutritional Therapeutic Immuno-Enhancer
- Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils
- Severe pustular lesions induced by topical immunotherapy with squaric acid dibutylester for alopecia totalis
- 576 INTASYL PH-762: Intratumoral immunotherapy targeting PD-1
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- ES01.01 Chemotherapy is Strictly Additive to Immunotherapy